PNC Financial Services Group’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$513K	Buy	1,985 +289	+17%	+$76.9K	﹤0.01%	1666
2025 Q4	$418K	Buy	1,696 +2	+0.1%	+$421	﹤0.01%	1795
2025 Q3	$299K	Buy	1,694 +272	+19%	+$40.7K	﹤0.01%	2017
2025 Q2	$195K	Sell	1,422 -719	-34%	-$106K	﹤0.01%	2217
2025 Q1	$386K	Buy	2,141 +461	+27%	+$77.5K	﹤0.01%	1710
2024 Q4	$263K	Buy	1,680 +36	+2%	+$6.39K	﹤0.01%	2008
2024 Q3	$299K	Buy	1,644 +158	+11%	+$30.5K	﹤0.01%	1905
2024 Q2	$273K	Buy	1,486 +565	+61%	+$94.9K	﹤0.01%	1928
2024 Q1	$164K	Buy	921 +601	+188%	+$83.5K	﹤0.01%	2316
2023 Q4	$39.7K	Sell	320 -100	-24%	-$11.1K	﹤0.01%	3083
2023 Q3	$48.7K	Buy	420 +48	+13%	+$5.86K	﹤0.01%	2973
2023 Q2	$43.7K	Buy	372 +124	+50%	+$12.7K	﹤0.01%	3141
2023 Q1	$19.9K	Hold	248	–	–	﹤0.01%	3498
2022 Q4	$19.6K	Buy	248 +70	+39%	+$5.2K	﹤0.01%	3479
2022 Q3	$12K	Buy	+178	New	+$12.9K	﹤0.01%	3670
2022 Q2	–	Sell	-28	Closed	-$2K	–	4617
2022 Q1	$2K	Buy	28 +26	+1,300%	+$1.62K	﹤0.01%	4203
2021 Q4	$0	Buy	+2	New	+$116	﹤0.01%	4534